BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21320347)

  • 1. Treatment utilization and barriers to treatment: results of a survey of dependent methamphetamine users.
    Kenny P; Harney A; Lee NK; Pennay A
    Subst Abuse Treat Prev Policy; 2011 Feb; 6():3. PubMed ID: 21320347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia.
    Wallace C; Galloway T; McKetin R; Kelly E; Leary J
    Drug Alcohol Rev; 2009 Nov; 28(6):592-9. PubMed ID: 19930011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of need, service use, and barriers to service access among female methamphetamine users in rural Appalachia.
    MacMaster SA
    Soc Work Public Health; 2013; 28(2):109-18. PubMed ID: 23461346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia.
    McKetin R; Kelly E
    Drug Alcohol Rev; 2007 Mar; 26(2):161-8. PubMed ID: 17364851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors related to psychosocial barriers to drug treatment among Chinese drug users.
    Kelly BC; Liu T; Zhang G; Hao W; Wang J
    Addict Behav; 2014 Aug; 39(8):1265-71. PubMed ID: 24813554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addiction and treatment experiences among active methamphetamine users recruited from a township community in Cape Town, South Africa: A mixed-methods study.
    Meade CS; Towe SL; Watt MH; Lion RR; Myers B; Skinner D; Kimani S; Pieterse D
    Drug Alcohol Depend; 2015 Jul; 152():79-86. PubMed ID: 25977205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studying Psychosocial Barriers to Drug Treatment Among Chinese Methamphetamine Users Using A 3-Step Latent Class Analysis.
    Wang J; Kelly BC; Liu T; Hao W
    J Subst Abuse Treat; 2016 Mar; 62():89-95. PubMed ID: 26738640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to methamphetamine withdrawal treatment in Australia: findings from a survey of AOD service providers.
    Pennay AE; Lee NK
    Drug Alcohol Rev; 2009 Nov; 28(6):636-40. PubMed ID: 19930017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year Changes in Methamphetamine Use, Dependence, and Remission in a Community-recruited Cohort.
    Lanyon C; Nambiar D; Higgs P; Dietze P; Quinn B
    J Addict Med; 2019; 13(2):159-165. PubMed ID: 30379780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rural drug users: factors associated with substance abuse treatment utilization.
    Oser CB; Leukefeld CG; Tindall MS; Garrity TF; Carlson RG; Falck R; Wang J; Booth BM
    Int J Offender Ther Comp Criminol; 2011 Jun; 55(4):567-86. PubMed ID: 20463206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health service utilisation attributable to methamphetamine use in Australia: Patterns, predictors and national impact.
    McKetin R; Degenhardt L; Shanahan M; Baker AL; Lee NK; Lubman DI
    Drug Alcohol Rev; 2018 Feb; 37(2):196-204. PubMed ID: 28294443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors related to abstinence from drug use and seeking help from medical services in Taiwanese heroin and methamphetamine users.
    Yen CN; Tang TC; Liu SC; Liu BY; Chang HT; Yen CF
    Kaohsiung J Med Sci; 2008 Feb; 24(2):63-71. PubMed ID: 18281222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcomes for methamphetamine users receiving outpatient counselling from the Stimulant Treatment Program in Australia.
    McKetin R; Dunlop AJ; Holland RM; Sutherland RA; Baker AL; Salmon AM; Hudson SL
    Drug Alcohol Rev; 2013 Jan; 32(1):80-7. PubMed ID: 22642414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to accessing methamphetamine treatment: A systematic review and meta-analysis.
    Cumming C; Troeung L; Young JT; Kelty E; Preen DB
    Drug Alcohol Depend; 2016 Nov; 168():263-273. PubMed ID: 27736680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exploration of self-perceived non-problematic use as a barrier to professional support for methamphetamine users.
    Quinn B; Stoové M; Papanastasiou C; Dietze P
    Int J Drug Policy; 2013 Nov; 24(6):619-23. PubMed ID: 23867050
    [No Abstract]   [Full Text] [Related]  

  • 16. Barriers to mental health care in Japan: Results from the World Mental Health Japan Survey.
    Kanehara A; Umeda M; Kawakami N;
    Psychiatry Clin Neurosci; 2015 Sep; 69(9):523-33. PubMed ID: 25523280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the WHO responsiveness concept in the Iranian mental healthcare system: a qualitative study of service users.
    Forouzan AS; Ghazinour M; Dejman M; Rafeiey H; San Sebastian M
    BMC Health Serv Res; 2011 Nov; 11():325. PubMed ID: 22115499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gaps in the ice: Methamphetamine in Australia; its history, treatment, and ramifications for users and their families.
    Gordon DG; de Jong G
    Int J Ment Health Nurs; 2018 Dec; 27(6):1861-1868. PubMed ID: 29869828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality, causes of death, and health status among methamphetamine users.
    Herbeck DM; Brecht ML; Lovinger K
    J Addict Dis; 2015; 34(1):88-100. PubMed ID: 25415384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new survey of methamphetamine users in treatment: who they are, why they like "meth," and why they need additional services.
    Maxwell JC
    Subst Use Misuse; 2014 May; 49(6):639-44. PubMed ID: 24093526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.